Expert Pitch
University of Alabama at Birmingham

UAB experts involved with COVID-19 vaccine research available to comment on outbreak, what's being reported, where concerns lie

Newswise — Experts from the University of Alabama at Birmingham are avaliable to comment on the state of COVID-19, including the development of an investigational compound  at UAB, next steps for a vaccine, what the state of the outbreak looks like, what concerns health officials have, risk to Americans and more. 

Richard Whitley, M.D., is an infectious disease researcher and clinician, and his NIH-funded research here at UAB has set the foundation for the investigational drug remdesivir to be used in treatment of novel coronavirus in patients in the U.S. and in China; the link above has more information about how Whitley and his team developed the compound of remdesivir, now released on a compassionate plea basis by Gilead Sciences. He can specifically talk about the development of a therapy for an outbreak such as this and what could be on the horizon in terms of mutations with the strain. He can also shed light on the effectiveness of quarantines and other related breaking updates.

Jeanne Marrazzo, M.D., MPH, director of UAB’s Division of Infectious Diseases, is part of an ID Leadership group that is overseeing the work of 9 national Vaccine & Treatment Evaluation Units through the NIH. Specifically, she is helping to spearhead next steps to get the first vaccine candidate for novel coronavirus into a VTEU led study hopefully by April. She can comment more broadly on what’s been reported, where people’s concerns need to lie, general prevention/safety tips, and more. She’s a great general ID resource for outbreaks such as this.

Both Whitley and Marrazzo are available for interviews by phone, email or for live or recorded interviews via LTN Global & ISDN from the UAB News Studio.




Filters close

Showing results

110 of 5636
Released: 13-May-2021 7:05 PM EDT
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation

Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:00 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.

Released: 13-May-2021 9:00 AM EDT
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET
Newswise

How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

Released: 13-May-2021 8:00 AM EDT
Dental procedures during pandemic are no riskier than a drink of water
Ohio State University

A new study’s findings dispel the misconception that patients and providers are at high risk of catching COVID-19 at the dentist’s office.

Newswise:Video Embedded lung-damage-not-the-culprit-for-post-covid-exercise-limitations
VIDEO
Released: 13-May-2021 7:00 AM EDT
Lung Damage Not the Culprit for Post-COVID Exercise Limitations
American Physiological Society (APS)

A new study suggests the lungs may not be the main factor that reduce exercise ability in people recovering from severe COVID-19. Anemia and muscle dysfunction also play a role. The study is published ahead of print in the Journal of Applied Physiology. It was chosen as an APSselect article for May.


Showing results

110 of 5636

close
2.20093